Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Cetyl Myristoleate (CMO) | Urolithin A | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | — | — |
| Timing | — | — |
| Cycle Duration | — | — |
| Evidence Level | Limited-Moderate | Moderate-Strong |
Fatty acid ester with anti-inflammatory and joint-lubricating properties. Modulates immune response by inhibiting 5-lipoxygenase and modulating prostaglandin synthesis. Reduces joint inflammation and improves range of motion in arthritic conditions.
Gut metabolite of ellagitannins that activates mitophagy — selective clearance of damaged mitochondria. Improves mitochondrial function, muscle endurance, and cellular energy production. Only ~40% of population can produce it endogenously.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →